Commit To Buy Jounce Therapeutics At $5, Earn 23.3% Annualized Using Options

Investors eyeing a purchase of Jounce Therapeutics Inc (JNCE) stock, but tentative about paying the going market price of $6.45/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the March 2019 put at the $5 strike, which has a bid at the time of this writing of 55 cents..